Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2013; 19(5): 761-768
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.761
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.761
Figure 1 Forest plot.
A: Overall morbidity; B: Severe complications; C: Overall sinusoidal dilation; D: Moderate or severe sinusoidal dilation. Bev: Bevacizumab.
- Citation: Li DB, Ye F, Wu XR, Wu LP, Chen JX, Li B, Zhou YM. Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases. World J Gastroenterol 2013; 19(5): 761-768
- URL: https://www.wjgnet.com/1007-9327/full/v19/i5/761.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i5.761